These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus. Yang W; Liu J; Blažeković B; Sun Y; Ma S; Ren C; Vladimir-Knežević S; Li C; Xing Y; Tian G; Wang Y BMC Complement Altern Med; 2018 May; 18(1):169. PubMed ID: 29848316 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. El-Azizi M; Rao S; Kanchanapoom T; Khardori N Ann Clin Microbiol Antimicrob; 2005 Jan; 4():2. PubMed ID: 15638934 [TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms. Dosler S; Mataraci E Peptides; 2013 Nov; 49():53-8. PubMed ID: 23988790 [TBL] [Abstract][Full Text] [Related]
12. Estimation of Minimum Biofilm Eradication Concentration (MBEC) on Okae Y; Nishitani K; Sakamoto A; Kawai T; Tomizawa T; Saito M; Kuroda Y; Matsuda S Front Cell Infect Microbiol; 2022; 12():896978. PubMed ID: 35846761 [TBL] [Abstract][Full Text] [Related]
13. Anti-biofilm activity of dalbavancin against methicillin-resistant Silva V; Miranda C; Bezerra M; Antão HS; Guimarães J; Prada J; Pires I; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P J Chemother; 2021 Nov; 33(7):469-475. PubMed ID: 33904369 [TBL] [Abstract][Full Text] [Related]
14. Pentacyclic Triterpenoids as Antibiofilm Agents against Methicillinresistant and Biofilm-forming Chung PYK; Gan MY; Chin BY Curr Pharm Biotechnol; 2022; 23(6):828-834. PubMed ID: 34365946 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and antibacterial activities of a heteroscorpionate derivative platinum complex against methicillin-resistant Nam-Cha SH; Domínguez-Jurado E; Tinoco-Valencia SL; Pérez-Tanoira R; Morata-Moreno N; Alfaro-Ruiza R; Lara-Sánchez A; Esteban J; Luján R; Alonso-Moreno C; Seguí P; Ocaña A; Gónzalez ÁL; Aguilera-Correa JJ; Pérez-Martínez FC; Alarcón MM Front Cell Infect Microbiol; 2023; 13():1100947. PubMed ID: 37051297 [No Abstract] [Full Text] [Related]